Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:FLKS

Flex Pharma (FLKS) Stock Price, News & Analysis

→ **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad)
Free FLKS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.46
▼
$0.50
50-Day Range
$0.57
▼
$14.51
52-Week Range
$0.26
▼
$1.49
Volume
42,883 shs
Average Volume
2.03 million shs
Market Capitalization
$8.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsSocial Media
FLKS stock logo

About Flex Pharma Stock (NASDAQ:FLKS)

Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps, spasms, and spasticity associated with neurological conditions and exercise-associated muscle cramps in the United States. It operates in two segments, Consumer Operations and Drug Development. The company's lead drug candidate is FLX-787, a single molecule, chemically synthesized, and dual transient receptor potential V1/A1 ion channel activator, which completed an exploratory Phase II clinical trial in Australia for the treatment of patients with multiple sclerosis. It also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. The company markets and sells its HOTSHOT products online through its direct-to-consumer Website and through third-party Websites, including a retailer that offers international shipping. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.

FLKS Stock News Headlines

April 4, 2024 | seekingalpha.com
Flex Ltd.: Undervalued With Solid Fundamentals
November 17, 2023 | seekingalpha.com
FLEX LNG Ltd. 2023 Q3 - Results - Earnings Call Presentation
October 30, 2023 | msn.com
Unforgettable Patients: A guy came to the ER for a scratch on his neck and "feeling drowsy." As we start the routine workups, he suddenly drops dead. Days later, his autopsy ...
September 4, 2023 | msn.com
ANGLE release Portrait Flex CTC assay
September 1, 2023 | msn.com
Why flex work is as important as pay for some
June 3, 2023 | news.yahoo.com
22-year-old woman arrested in Forks after threatening homeowner with gun
May 24, 2023 | fool.com
Flex (NASDAQ: FLEX)
March 28, 2023 | wsj.com
Flex Ltd.
March 25, 2023 | forbes.com
That's All Folks: Why the Writing Is on the Wall at Microsoft
March 24, 2023 | bbc.co.uk
Folk Club with Lynette Fay
March 10, 2023 | msn.com
California flexed its muscle on abortion rights. Will more states and businesses follow?
December 12, 2022 | news.yahoo.com
Company to add new flex work space to Shelby
September 7, 2022 | finance.yahoo.com
Optimal Flex Plays: We are back baby!
August 11, 2022 | seekingalpha.com
OncoCyte Corporation (OCX) CEO Ronnie Andrews on Q2 2022 Results - Earnings Call Transcript
June 16, 2022 | seekingalpha.com
The Kraft Heinz Company's (KHC) Management Presents at Deutsche Bank Annual dbAccess Global Consumer Conference (Transcript)
June 15, 2022 | seekingalpha.com
The Kraft Heinz Company (KHC) Presents at Deutsche Bank Annual dbAccess Global Consumer Conference (Transcript)
June 8, 2022 | finance.yahoo.com
Over 500+ Weight Loss Smoothie Recipes Revealed By Cocinaré For Their New Gopower eLite Personal Portable Blender Launch
May 21, 2022 | dailymail.co.uk
Monkeypox is now spotted in Italy and Sweden — bringing number of countries with confirmed or suspected cases to SEVEN
May 20, 2022 | msn.com
My Fair Lady, The Breach and Rambert: The best of the week’s live reviews
May 16, 2022 | seekingalpha.com
Ginkgo Bioworks Holdings, Inc. (DNA) CEO Jason Kelly on Q1 2022 Results - Earnings Call Transcript
May 14, 2022 | seekingalpha.com
Zymergen, Inc. (ZY) CEO Jay Flatley on Q1 2022 Results - Earnings Call Transcript
May 5, 2022 | seekingalpha.com
Becton, Dickinson and Company (BDX) CEO Thomas Polen on Q2 2022 Results - Earnings Call Transcript
April 14, 2022 | ca.finance.yahoo.com
Toyota's first EV will start at $42,000
March 6, 2022 | yahoo.com
Biden May Extend Pause On Student Loan Payments Again: Top Aide
January 31, 2022 | msn.com
Ford F-150, Chevy Silverado, Ram 3500 Flex Some Muscle In Tug Of War
See More Headlines

Company Calendar

Last Earnings
5/01/2019
Today
5/20/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FLKS
CUSIP
N/A
CIK
1615219
Web
www.flex-pharma.com
Phone
617-874-1821
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-21,920,000.00
Net Margins
-1,208.42%
Pretax Margin
N/A
Return on Equity
-98.04%
Return on Assets
-83.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.86
Quick Ratio
6.74

Sales & Book Value

Annual Sales
$840,000.00
Price / Sales
10.64
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.51 per share
Price / Book
0.97

Miscellaneous

Outstanding Shares
18,070,000
Free Float
N/A
Market Cap
$8.94 million
Optionable
Not Optionable
Beta
1.65

Key Executives

  • Dr. William K. McVicar (Age 61)
    Pres, CEO & Director
  • Dr. Roderick MacKinnon (Age 63)
    Co-Founder & Co-Chair of Scientific Advisory Board
  • Mr. John McCabe (Age 49)
    CFO, Treasurer & Sec.
  • Dr. Thomas C. Wessel (Age 63)
    Outside Advisor
  • Dr. Bruce Bean
    Co-Founder, Co-Chair of Scientific Advisory Board & Board Observer

Key Competitors

View All Competitors

FLKS Stock Analysis - Frequently Asked Questions

How were Flex Pharma's earnings last quarter?

Flex Pharma Inc (NASDAQ:FLKS) announced its quarterly earnings results on Wednesday, May, 1st. The biotechnology company reported ($0.12) earnings per share for the quarter. The biotechnology company earned $0.11 million during the quarter. Flex Pharma had a negative net margin of 1,208.42% and a negative trailing twelve-month return on equity of 98.04%.

What other stocks do shareholders of Flex Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Flex Pharma investors own include Ocular Therapeutix (OCUL), Micron Technology (MU), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX), Gilead Sciences (GILD), Histogenics (HSGX), TG Therapeutics (TGTX), TherapeuticsMD (TXMD), Celldex Therapeutics (CLDX) and Melinta Therapeutics (MLNT).

When did Flex Pharma IPO?

Flex Pharma (FLKS) raised $60 million in an initial public offering on Thursday, January 29th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Jefferies and Piper Jaffray acted as the underwriters for the IPO and JMP Securities, Cantor Fitzgerald and Roth Capital Partners were co-managers.

This page (NASDAQ:FLKS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
The ONE AI Stock to own now. (It’s not Nvidia.)
Weiss Ratings
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
Urgent Nvidia Warning
Altimetry
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts